BLUE(Delisted)
bluebird bioยทNASDAQ
--
--(--)
BLUE fundamentals
bluebird bio (BLUE) released its earnings on May 14, 2025: revenue was 38.71M (YoY +108.13%), beat estimates; EPS was -2.98 (YoY -705.41%), beat estimates.
Revenue / YoY
38.71M
+108.13%
EPS / YoY
-2.98
-705.41%
Report date
May 14, 2025
EPS
Revenue
Revenue & Expenses
BLUE has released its 2025 Q1 earnings report, with revenue of 38.71M, reflecting a YoY change of 108.43%, and net profit of -29.07M, showing a YoY change of 58.36%. The Sankey diagram below clearly presents BLUE's revenue sources and cost distribution.
Key Indicators
bluebird bio (BLUE) key financial stats and ratios, covering profitability, financial health, and leverage.
bluebird bio (BLUE)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
bluebird bio (BLUE)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
bluebird bio (BLUE)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does bluebird bio (BLUE) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track bluebird bio (BLUE) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
No Data
